An unlikely trio award $75M to battle heart disease, set new research paradigm
The American Heart Association, Verily and AstraZeneca are each awarding $25 million to a five-year research project that aims to unlock the mysteries of coronary heart disease and turn the conventional model of scientific inquiry on its head.